Performance of Two Screening Questionnaires for Inflammatory Arthritis in Patients with Inflammatory Bowel Disease

Table 1

Disease characteristics of the study population.

Disease feature	Study population : 112
Age (yrs, mean ± SD)	33.12 ± 7.19
Disease duration (yrs, mean ± SD)	8 ± 5.6
BMI (Kg/m^2)	23.3 ± 4.5
Women	48 (42.9%)
Men	64 (57.1%)
UC	44 (39.3%)
CD	68 (60.7%)
IBD family history	21 (18.7%)
Biologics	42 (37.5%)
Classic immunosuppressants	51 (45.5%)
Corticoids	11 (9.8%)
IBD surgery	28 (25%)
Diabetes	0 (0%)
Hypertension	0 (0%)
Dyslipidemia	2 (1.8%)
Smokers	24 (21.4%)
Alcohol	25 (22.3%)
Psoriasis	11 (9.8%)
Psoriasis family history	14 (12.5%)
Asthma	14 (12.5%)
Clinical enthesitis	5 (4.5%)
Dactylitis	3 (2.7%)

BMI: body mass index; UC: ulcerative colitis; CD: Crohn’s disease; IBD: inflammatory boweldisease. After clinical examination.